Xiaozhi Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiaozhi Zhao has a total of 228 co-authors. Here are the top co-authors by number of shared publications:
- Hongqian Guo
Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
12 shared publications Jie Gao
Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China
6 shared publications- Jinhui Wu
Jiangsu Key Laboratory for Nano Technology, Nanjing University, Nanjing, 210093, P. R. China
6 shared publications - Hui Wei
Nanjing University
5 shared publications Wei Chen
Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Institute of Urology Nanjing University, No. 321 Zhongshan Road, Nanjing 210008, Jiangsu, China
5 shared publicationsWenmin Cao
Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Institute of Urology Nanjing University, No. 321 Zhongshan Road, Nanjing 210008, Jiangsu, China
5 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by Wolters Kluwer Health in Asian Journal of Andrology
- Vol. 28 (6) , 929-937
Body mass index and semen quality in 11 154 men: evidence from a large-scale andrology dataset
Obesity has been increasingly linked to impaired male reproductive function, yet the association between body mass index (BMI) and semen quality remains unclear, particularly in large Asian populations. In this retrospective cross-sectional study, we analyzed 11 154 men aged 18–50 years who underwent semen analysis at Nanjing Drum Tower Hospital (Nanjing, China), between January 2024 and January 2025. Semen parameters were assessed according to the World Health Organization Laboratory Manual (6 th edition), and sperm kinematics were measured via computer-aided sperm analysis. BMI was modeled both as a continuous variable and as a categorical variable, and associations of BMI with sperm parameters were evaluated using multivariable linear regression, sensitivity analyses, restricted cubic splines, and locally estimated scatterplot smoothing (LOESS) curves. The mean BMI of the participants was 26.3 (standard deviation: 3.8) kg m −2 . A higher BMI was associated with modest but consistent reductions in semen volume, total sperm count, sperm concentration, and selected sperm kinematic parameters. No U- or J-shaped associations were observed. The results of the restricted cubic spline analyses suggested only modest nonlinearity in the relationships of BMI with sperm concentration and total sperm count, whereas the associations with semen volume and kinematic parameters were largely linear. The results of the sensitivity analyses were consistent with the primary findings. In the subset analyses, obesity was associated with more severe sperm DNA fragmentation, whereas exploratory hormone analyses in men with obesity indicated that a higher BMI was associated with lower total testosterone levels, higher estradiol levels, and a lower total testosterone/estradiol (TT/E2) ratio, which were also related to a lower semen volume. Overall, a higher BMI was linearly and inversely associated with several semen parameters, although the effect sizes were modest.
- 25 September 2026
- Published by Wolters Kluwer Health in Asian Journal of Andrology
- Vol. 28 (6) , 929-937
Open AccessBody mass index and semen quality in 11 154 men: evidence from a large-scale andrology dataset
Obesity has been increasingly linked to impaired male reproductive function, yet the association between body mass index (BMI) and semen quality remains unclear, particularly in large Asian populations. In this retrospective cross-sectional study, we analyzed 11 154 men aged 18–50 years who underwent semen analysis at Nanjing Drum Tower Hospital (Nanjing, China), between January 2024 and January 2025. Semen parameters were assessed according to the World Health Organization Laboratory Manual (6 th edition), and sperm kinematics were measured via computer-aided sperm analysis. BMI was modeled both as a continuous variable and as a categorical variable, and associations of BMI with sperm parameters were evaluated using multivariable linear regression, sensitivity analyses, restricted cubic splines, and locally estimated scatterplot smoothing (LOESS) curves. The mean BMI of the participants was 26.3 (standard deviation: 3.8) kg m −2 . A higher BMI was associated with modest but consistent reductions in semen volume, total sperm count, sperm concentration, and selected sperm kinematic parameters. No U- or J-shaped associations were observed. The results of the restricted cubic spline analyses suggested only modest nonlinearity in the relationships of BMI with sperm concentration and total sperm count, whereas the associations with semen volume and kinematic parameters were largely linear. The results of the sensitivity analyses were consistent with the primary findings. In the subset analyses, obesity was associated with more severe sperm DNA fragmentation, whereas exploratory hormone analyses in men with obesity indicated that a higher BMI was associated with lower total testosterone levels, higher estradiol levels, and a lower total testosterone/estradiol (TT/E2) ratio, which were also related to a lower semen volume. Overall, a higher BMI was linearly and inversely associated with several semen parameters, although the effect sizes were modest.
- 13 September 2026
- Published by Wiley in Clinical Genetics
- Vol. 110 (6) , 763-767
A Homozygous Variant in DMRTB1 Is Associated With Non‐Obstructive Azoospermia in Humans
Non‐obstructive azoospermia (NOA) represents the most severe form of male infertility, and the pathogenesis in partial patients can be attributed to endocrine dysfunction or heritable genetic variants. Although the application of whole‐exome sequencing (WES) has facilitated the identification of numerous pathogenic genes associated with NOA, the genetic etiology of a significant proportion of cases remains elusive. In this study, we identified an NOA patient carrying a novel variant in DMRTB1 (c.792–797del, p.265–266del). The variant was rare in public databases and predicted to be likely pathogenic according to the American College of Medical Genetics (ACMG) guidelines. Structural modeling performed by SWISS‐MODEL revealed the localized structural perturbations within residues 254–266, which may induce functional alterations. Histological analysis (H&E staining) of the testicular tissue revealed a complete absence of mature sperm within the seminiferous tubules, which is consistent with the essential role of this gene demonstrated in Dmrt6 knockout mice. Our findings demonstrate that the identified DMRTB1 variant is closely associated with the pathogenesis of NOA, thereby providing valuable genetic evidence for the diagnosis of NOA.
- 13 September 2026
- Published by Wiley in Clinical Genetics
- Vol. 110 (6) , 763-767
A Homozygous Variant in DMRTB1 Is Associated With Non‐Obstructive Azoospermia in Humans
Non‐obstructive azoospermia (NOA) represents the most severe form of male infertility, and the pathogenesis in partial patients can be attributed to endocrine dysfunction or heritable genetic variants. Although the application of whole‐exome sequencing (WES) has facilitated the identification of numerous pathogenic genes associated with NOA, the genetic etiology of a significant proportion of cases remains elusive. In this study, we identified an NOA patient carrying a novel variant in DMRTB1 (c.792–797del, p.265–266del). The variant was rare in public databases and predicted to be likely pathogenic according to the American College of Medical Genetics (ACMG) guidelines. Structural modeling performed by SWISS‐MODEL revealed the localized structural perturbations within residues 254–266, which may induce functional alterations. Histological analysis (H&E staining) of the testicular tissue revealed a complete absence of mature sperm within the seminiferous tubules, which is consistent with the essential role of this gene demonstrated in Dmrt6 knockout mice. Our findings demonstrate that the identified DMRTB1 variant is closely associated with the pathogenesis of NOA, thereby providing valuable genetic evidence for the diagnosis of NOA.
- Open Access
Variants in ZZS Complex‐Associated Genes TEX11 and M1AP Are Responsible for Male Infertility and Nonobstructive Azoospermia
Background: Nonobstructive azoospermia (NOA) is the most severe form of male infertility, with genetic factors contributing to approximately 30% of cases. However, only a small fraction of all NOA cases can be explained by the current genetic findings. ZZS complex participates in meiotic recombination and is necessary for spermatogenesis. Objectives: To expand the variant spectrum of ZZS complex‐associated genes in male infertility and validate the pathogenicity of identified variants in patients with NOA. Materials/Methods: A total of 108 Chinese NOA patients were recruited, whole‐exome sequencing (WES) and subsequent genetic analysis were performed to identify candidate pathogenic variants. Reverse‐transcript PCR (RT‐PCR) and quantitative reverse‐transcript PCR (RT‐qPCR) were performed to detect the mRNA expression of TEX11 and M1AP . Hematoxylin and eosin staining and immunofluorescence staining were performed on testicular sections obtained from patients’ biopsies. Results: Five variants in ZZS complex‐associated genes TEX11 and M1AP were identified from five NOA patients. These variants were either rare or absent in public human genetic databases and were predicted to be deleterious. Further functional analysis revealed that the mRNA expression levels of TEX11 and M1AP were significantly reduced in four of the affected patients. Hematoxylin and eosin staining revealed the loss of postmeiosis cells in seminiferous tubules of these patients. Immunofluorescence staining further confirmed the loss of spermatids and the zygotene arrest of meiosis. Discussion and Conclusion: Collectively, our findings provide compelling evidence for the pathogenicity of these five variants in the development of NOA. These results not only expand the genetic landscape of NOA but also offer valuable insights for future clinical screening and diagnostic strategies.
Open AccessVariants in ZZS Complex‐Associated Genes TEX11 and M1AP Are Responsible for Male Infertility and Nonobstructive Azoospermia
Background: Nonobstructive azoospermia (NOA) is the most severe form of male infertility, with genetic factors contributing to approximately 30% of cases. However, only a small fraction of all NOA cases can be explained by the current genetic findings. ZZS complex participates in meiotic recombination and is necessary for spermatogenesis. Objectives: To expand the variant spectrum of ZZS complex‐associated genes in male infertility and validate the pathogenicity of identified variants in patients with NOA. Materials/Methods: A total of 108 Chinese NOA patients were recruited, whole‐exome sequencing (WES) and subsequent genetic analysis were performed to identify candidate pathogenic variants. Reverse‐transcript PCR (RT‐PCR) and quantitative reverse‐transcript PCR (RT‐qPCR) were performed to detect the mRNA expression of TEX11 and M1AP . Hematoxylin and eosin staining and immunofluorescence staining were performed on testicular sections obtained from patients’ biopsies. Results: Five variants in ZZS complex‐associated genes TEX11 and M1AP were identified from five NOA patients. These variants were either rare or absent in public human genetic databases and were predicted to be deleterious. Further functional analysis revealed that the mRNA expression levels of TEX11 and M1AP were significantly reduced in four of the affected patients. Hematoxylin and eosin staining revealed the loss of postmeiosis cells in seminiferous tubules of these patients. Immunofluorescence staining further confirmed the loss of spermatids and the zygotene arrest of meiosis. Discussion and Conclusion: Collectively, our findings provide compelling evidence for the pathogenicity of these five variants in the development of NOA. These results not only expand the genetic landscape of NOA but also offer valuable insights for future clinical screening and diagnostic strategies.
- 19 May 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1)
Modifiable predictors of patency after microsurgical vasoepididymostomy: associations of adjunctive escin, prior percutaneous epididymal sperm aspiration, and postoperative ejaculatory frequency
To examine associations of adjunctive oral escin, prior percutaneous epididymal sperm aspiration (PESA), and early postoperative ejaculatory frequency with time to and final technical patency after microsurgical vasoepididymostomy (MVE), and to derive an exploratory prognostic model for individualized counseling. We conducted a retrospective cohort study of 134 men with obstructive azoospermia (OA) who underwent MVE between June 2022 and August 2024. Patients received standard care alone (Control Cohort, n = 71) or standard care plus adjunctive oral escin (Combined Cohort, n = 63). Key variables included prior PESA and self-reported postoperative ejaculatory frequency during the first 3 months (< 2 vs. ≥2 times/week). Final technical patency was defined as the presence of any sperm in the ejaculate during follow-up. Time to patency was analyzed in the full cohort using Kaplan-Meier curves and multivariable Cox regression, with patients who remained non-patent by 12 months treated as right-censored observations at 12 months. Independent predictors of final technical patency were evaluated using multivariable logistic regression. To ensure model stability, an exploratory prognostic model was constructed using the independent predictors, and its discrimination was assessed by ROC analysis. The Combined Cohort showed a higher final technical patency rate than the Control Cohort (87.3% vs. 73.2%, P = 0.043) and a shorter time to patency (log-rank P < 0.001). In multivariable Cox analysis, adjunctive escin was associated with earlier patency (HR = 1.645, P = 0.013), whereas prior PESA was independently associated with delayed patency (HR = 0.505, P = 0.001). Bilateral anastomosis (HR = 2.627, P = 0.006) and high postoperative ejaculatory frequency (HR = 1.916, P = 0.005) were also independently associated with earlier patency. In multivariable logistic regression, prior PESA was independently associated with lower final patency (OR = 0.238, P = 0.043), whereas bilateral anastomosis (OR = 5.039, P = 0.040) and high postoperative ejaculatory frequency (OR = 3.004, P = 0.041) were independently associated with higher final patency. The refined prognostic model demonstrated good discrimination (AUC = 0.778) and achieved an events-per-variable ratio of 9.0. Modifiable perioperative factors were associated with MVE outcomes. Adjunctive escin was associated with earlier technical patency but not independently with final technical patency. High ejaculatory frequency during the first 3 months was associated with both earlier and higher final technical patency, whereas prior PESA was associated with delayed and lower patency. These findings may inform perioperative counseling, but should be interpreted as observational and exploratory.
- 19 May 2026
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1)
Modifiable predictors of patency after microsurgical vasoepididymostomy: associations of adjunctive escin, prior percutaneous epididymal sperm aspiration, and postoperative ejaculatory frequency
To examine associations of adjunctive oral escin, prior percutaneous epididymal sperm aspiration (PESA), and early postoperative ejaculatory frequency with time to and final technical patency after microsurgical vasoepididymostomy (MVE), and to derive an exploratory prognostic model for individualized counseling. We conducted a retrospective cohort study of 134 men with obstructive azoospermia (OA) who underwent MVE between June 2022 and August 2024. Patients received standard care alone (Control Cohort, n = 71) or standard care plus adjunctive oral escin (Combined Cohort, n = 63). Key variables included prior PESA and self-reported postoperative ejaculatory frequency during the first 3 months (< 2 vs. ≥2 times/week). Final technical patency was defined as the presence of any sperm in the ejaculate during follow-up. Time to patency was analyzed in the full cohort using Kaplan-Meier curves and multivariable Cox regression, with patients who remained non-patent by 12 months treated as right-censored observations at 12 months. Independent predictors of final technical patency were evaluated using multivariable logistic regression. To ensure model stability, an exploratory prognostic model was constructed using the independent predictors, and its discrimination was assessed by ROC analysis. The Combined Cohort showed a higher final technical patency rate than the Control Cohort (87.3% vs. 73.2%, P = 0.043) and a shorter time to patency (log-rank P < 0.001). In multivariable Cox analysis, adjunctive escin was associated with earlier patency (HR = 1.645, P = 0.013), whereas prior PESA was independently associated with delayed patency (HR = 0.505, P = 0.001). Bilateral anastomosis (HR = 2.627, P = 0.006) and high postoperative ejaculatory frequency (HR = 1.916, P = 0.005) were also independently associated with earlier patency. In multivariable logistic regression, prior PESA was independently associated with lower final patency (OR = 0.238, P = 0.043), whereas bilateral anastomosis (OR = 5.039, P = 0.040) and high postoperative ejaculatory frequency (OR = 3.004, P = 0.041) were independently associated with higher final patency. The refined prognostic model demonstrated good discrimination (AUC = 0.778) and achieved an events-per-variable ratio of 9.0. Modifiable perioperative factors were associated with MVE outcomes. Adjunctive escin was associated with earlier technical patency but not independently with final technical patency. High ejaculatory frequency during the first 3 months was associated with both earlier and higher final technical patency, whereas prior PESA was associated with delayed and lower patency. These findings may inform perioperative counseling, but should be interpreted as observational and exploratory.
- Open Access
- 12 May 2026
- Published by Wiley in Advanced Science
- Vol. 13 (44) , e75596
Engineered Carbon Dots from a Traditional Herb Pair Orchestrate Concurrent Antioxidant and AP‐1‐Mediated Inflammation to Attenuate Renal Ischemia‐Reperfusion Injury
Renal ischemia‐reperfusion (I/R) injury, a primary cause of acute kidney injury (AKI), is driven by a self‐amplifying loop of oxidative burst and immune cell infiltration. In this work, the classical herb pair Astragalus membranaceus (AM) and Angelica sinensis (AS) is employed as a composite precursor to synthesize nitrogen‐rich carbon‐dot nanozymes (AM‐AS@CDs) via a one‐step hydrothermal method. AM‑AS@CDs exhibit superoxide dismutase (SOD)‐mimetic activity superior to that of CDs derived from single herbs. In vitro, AM‐AS@CDs effectively alleviate oxidative stress‐induced cellular damage and significantly inhibit apoptosis. In vivo, AM‐AS@CDs markedly attenuate I/R‐induced AKI and reduce immune cell infiltration in renal tissues. Transcriptomic analyses reveal that AM‐AS@CDs downregulate the expression and phosphorylation of Fosl1 and c‐Jun. Consequently, the AP‐1‐chemokine signaling axis is disrupted, which reduces immune cell recruitment. Furthermore, AM‐AS@CDs restore redox homeostasis by upregulating antioxidant enzymes such as SOD, glutathione peroxidase 4 (GPX4), and catalase (CAT). They also attenuate the excessive activation of the Nrf2/HO‐1 pathway. Overall, this precursor‐formulation strategy enables precise modulation of heteroatom doping and surface chemistry in CDs. AM‐AS@CDs effectively interrupt the oxidative‐inflammatory positive feedback loop through dual mechanisms. These findings provide both theoretical and material foundations for the development of natural product‐based nanozymes for I/R‐related diseases.
- 12 May 2026
- Published by Wiley in Advanced Science
- Vol. 13 (44) , e75596
Open AccessEngineered Carbon Dots from a Traditional Herb Pair Orchestrate Concurrent Antioxidant and AP‐1‐Mediated Inflammation to Attenuate Renal Ischemia‐Reperfusion Injury
Renal ischemia‐reperfusion (I/R) injury, a primary cause of acute kidney injury (AKI), is driven by a self‐amplifying loop of oxidative burst and immune cell infiltration. In this work, the classical herb pair Astragalus membranaceus (AM) and Angelica sinensis (AS) is employed as a composite precursor to synthesize nitrogen‐rich carbon‐dot nanozymes (AM‐AS@CDs) via a one‐step hydrothermal method. AM‑AS@CDs exhibit superoxide dismutase (SOD)‐mimetic activity superior to that of CDs derived from single herbs. In vitro, AM‐AS@CDs effectively alleviate oxidative stress‐induced cellular damage and significantly inhibit apoptosis. In vivo, AM‐AS@CDs markedly attenuate I/R‐induced AKI and reduce immune cell infiltration in renal tissues. Transcriptomic analyses reveal that AM‐AS@CDs downregulate the expression and phosphorylation of Fosl1 and c‐Jun. Consequently, the AP‐1‐chemokine signaling axis is disrupted, which reduces immune cell recruitment. Furthermore, AM‐AS@CDs restore redox homeostasis by upregulating antioxidant enzymes such as SOD, glutathione peroxidase 4 (GPX4), and catalase (CAT). They also attenuate the excessive activation of the Nrf2/HO‐1 pathway. Overall, this precursor‐formulation strategy enables precise modulation of heteroatom doping and surface chemistry in CDs. AM‐AS@CDs effectively interrupt the oxidative‐inflammatory positive feedback loop through dual mechanisms. These findings provide both theoretical and material foundations for the development of natural product‐based nanozymes for I/R‐related diseases.
- Open Access
- 23 February 2026
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 24 (1)
DNAH3 interacts with DNALI1 and is required for sperm flagellum function and male fertility
The inner dynein arm (IDA) plays a crucial role in regulating ciliary and flagellar beating; however, the molecular mechanisms underlying IDA regulation re
- 23 February 2026
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 24 (1)
Open AccessDNAH3 interacts with DNALI1 and is required for sperm flagellum function and male fertility
The inner dynein arm (IDA) plays a crucial role in regulating ciliary and flagellar beating; however, the molecular mechanisms underlying IDA regulation re
- Open Access
- 30 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 30
Biomimetic Nanotechnology Overcoming the Blood–Testis Barrier for Testicular Protection in Chemotherapy
Cancer patients exposed to chemotherapeutic drugs and whole-body radiation can result in testicular injury and germ cell loss. One of the mechanisms is that these drugs lead to the accumulation of reactive oxygen species (ROS) in the testes, which has been documented to cause testicular damage. Therefore, this highlights the critical need for ROS clearance in testes to preserve male fertility during cancer treatment. The blood–testis barrier (BTB) poses a major challenge, due to the absence of effective pharmaceutical agents that can penetrate this barrier to neutralize ROS effectively. We synthesized nanomaterials based on manganese-superoxide dismutase (PCN-222-Mn), demonstrating the ability to cross BTB and facilitate ROS clearance. Real-time T1-weighted magnetic resonance imaging confirmed the targeted delivery of PCN-222-Mn to the testes in mice. In murine models of testicular injury induced by cyclophosphamide, PCN-222-Mn showed major therapeutic effects by protecting germ cells and associated somatic cells through ROS reduction and autophagy enhancement. Additionally, PCN-222-Mn was demonstrated to penetrate Sertoli cells via clathrin-mediated and caveolae-mediated endocytosis and expelled by exocytosis, facilitating transport across the BTB. This research not only proposes a viable therapeutic approach to preserve male fertility during cancer treatment but also underscores the transformative potential of nanozymes in clinical settings.
- 30 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 30
Open AccessBiomimetic Nanotechnology Overcoming the Blood–Testis Barrier for Testicular Protection in Chemotherapy
Cancer patients exposed to chemotherapeutic drugs and whole-body radiation can result in testicular injury and germ cell loss. One of the mechanisms is that these drugs lead to the accumulation of reactive oxygen species (ROS) in the testes, which has been documented to cause testicular damage. Therefore, this highlights the critical need for ROS clearance in testes to preserve male fertility during cancer treatment. The blood–testis barrier (BTB) poses a major challenge, due to the absence of effective pharmaceutical agents that can penetrate this barrier to neutralize ROS effectively. We synthesized nanomaterials based on manganese-superoxide dismutase (PCN-222-Mn), demonstrating the ability to cross BTB and facilitate ROS clearance. Real-time T1-weighted magnetic resonance imaging confirmed the targeted delivery of PCN-222-Mn to the testes in mice. In murine models of testicular injury induced by cyclophosphamide, PCN-222-Mn showed major therapeutic effects by protecting germ cells and associated somatic cells through ROS reduction and autophagy enhancement. Additionally, PCN-222-Mn was demonstrated to penetrate Sertoli cells via clathrin-mediated and caveolae-mediated endocytosis and expelled by exocytosis, facilitating transport across the BTB. This research not only proposes a viable therapeutic approach to preserve male fertility during cancer treatment but also underscores the transformative potential of nanozymes in clinical settings.
- Open Access
- 13 January 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1707946
Predicting HER2 overexpression in prostate cancer using machine learning: implications for personalized therapy
Background: Human Epidermal Growth Factor Receptor 2 (HER2), a component of the epidermal growth factor receptor family, is thought to be related to advanced prostate cancer (PCa) when overexpressed. Currently, most research on HER2 is limited to molecular pathology, with relatively few studies focused on imaging aspects. Objectives: To develop a predictive model by extracting high-throughput radiomics features from magnetic resonance imaging and combining them with clinical characteristics for predicting HER2 overexpression. Materials and methods: A total of 201 patients who underwent radical prostatectomy and HER2 immunohistochemistry were retrospectively enrolled. These patients were randomly divided into a training set (n=160) and a test set (n=41). Multimodal radiomics features extracted from T2-weighted imaging (T2WI) and apparent diffusion coefficient maps (ADC) were selected using Mann-Whitney U test and least absolute shrinkage and selection operator (LASSO) with ten-fold cross-validation. Predictive models were developed and evaluated based on discrimination and clinical utility. Results: The combined model integrating ISUP Grade, PSA and Radscore achieved an area under the curve (AUC) of 0.841 (95% CI: 0.697-0.955) in the test set, significantly outperforming the clinical model (AUC = 0.580; p = 0.02, DeLong test) and demonstrating a modest improvement over the Radscore model (AUC = 0.838 (0.693-0.951). Evaluation results showed consistent discriminatory power: 0.78 accuracy, 0.77 sensitivity, and 0.79 specificity, indicating well-balanced performance between positive and negative classes. Decision curve analysis and Waterfall plot demonstrated strong clinical applicability. Conclusion: The combined model effectively predicts HER2 overexpression in prostate cancer, with potential to inform more personalized treatment strategies for HER2-overexpressing PCa patients.
- 13 January 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1707946
Open AccessPredicting HER2 overexpression in prostate cancer using machine learning: implications for personalized therapy
Background: Human Epidermal Growth Factor Receptor 2 (HER2), a component of the epidermal growth factor receptor family, is thought to be related to advanced prostate cancer (PCa) when overexpressed. Currently, most research on HER2 is limited to molecular pathology, with relatively few studies focused on imaging aspects. Objectives: To develop a predictive model by extracting high-throughput radiomics features from magnetic resonance imaging and combining them with clinical characteristics for predicting HER2 overexpression. Materials and methods: A total of 201 patients who underwent radical prostatectomy and HER2 immunohistochemistry were retrospectively enrolled. These patients were randomly divided into a training set (n=160) and a test set (n=41). Multimodal radiomics features extracted from T2-weighted imaging (T2WI) and apparent diffusion coefficient maps (ADC) were selected using Mann-Whitney U test and least absolute shrinkage and selection operator (LASSO) with ten-fold cross-validation. Predictive models were developed and evaluated based on discrimination and clinical utility. Results: The combined model integrating ISUP Grade, PSA and Radscore achieved an area under the curve (AUC) of 0.841 (95% CI: 0.697-0.955) in the test set, significantly outperforming the clinical model (AUC = 0.580; p = 0.02, DeLong test) and demonstrating a modest improvement over the Radscore model (AUC = 0.838 (0.693-0.951). Evaluation results showed consistent discriminatory power: 0.78 accuracy, 0.77 sensitivity, and 0.79 specificity, indicating well-balanced performance between positive and negative classes. Decision curve analysis and Waterfall plot demonstrated strong clinical applicability. Conclusion: The combined model effectively predicts HER2 overexpression in prostate cancer, with potential to inform more personalized treatment strategies for HER2-overexpressing PCa patients.
- Open Access
- 1 January 2026
- Published by Wiley in Human Mutation
- Vol. 2026 (1) , 7629729
Pathogenic Variants in PET Complex Encoding Genes TDRD12 and EXD1 Impair piRNA Biogenesis and Cause Male Infertility
Background: Nonobstructive azoospermia (NOA), the most severe form of male infertility, has approximately 30% of its cases attributed to genetic factors. However, current genetic research only explains a small fraction of NOA cases. Methods: Here, 156 infertile Chinese patients diagnosed with idiopathic male infertility were recruited. Whole exome sequencing and subsequent bioinformatic analysis were performed to find candidate pathogenic variants. Sanger sequencing was used to validate the candidate variants. Quantitative reverse‐transcript PCR (RT‐qPCR) was performed to detect the mRNA expression of TDRD12 and related piRNA genes. Hematoxylin and eosin staining and immunofluorescence staining were performed on testicular sections obtained from patients′ biopsies. Intracytoplasmic sperm injection (ICSI) was applied for assisted fertilization. Additionally, small RNA sequencing was performed to identify the abnormalities of piRNA biogenesis. Results: We identified eight variants in PET (PIWI‐EXD1‐TDRD12) complex encoding genes TDRD12 and EXD1 from three NOA patients and one oligoasthenozoospermia patient. These variants, which were rare or absent in public human databases, were predicted to be deleterious. Notably, TDRD12 mRNA was absent in three NOA patients. Testicular histopathological analyses revealed that spermatogenesis was arrested at zygotene stage in patients carrying biallelic TDRD12 variants. Further immunofluorescence staining of L1ORF1p and small RNA sequencing revealed disruptions in piRNA biogenesis and subsequent derepression of retrotransposons. Further assisted reproduction outcomes showed that one of the individuals conceived successfully after ICSI. Conclusion: Overall, this study significantly expands the mutational phenotype of PET complex‐encoding genes and significantly advances our understanding of spermatogenic failure and male infertility. Our findings provide direct clinical and functional evidence that the function of the PET complex and piRNA biogenesis is highly conserved between humans and mice.
- 1 January 2026
- Published by Wiley in Human Mutation
- Vol. 2026 (1) , 7629729
Open AccessPathogenic Variants in PET Complex Encoding Genes TDRD12 and EXD1 Impair piRNA Biogenesis and Cause Male Infertility
Background: Nonobstructive azoospermia (NOA), the most severe form of male infertility, has approximately 30% of its cases attributed to genetic factors. However, current genetic research only explains a small fraction of NOA cases. Methods: Here, 156 infertile Chinese patients diagnosed with idiopathic male infertility were recruited. Whole exome sequencing and subsequent bioinformatic analysis were performed to find candidate pathogenic variants. Sanger sequencing was used to validate the candidate variants. Quantitative reverse‐transcript PCR (RT‐qPCR) was performed to detect the mRNA expression of TDRD12 and related piRNA genes. Hematoxylin and eosin staining and immunofluorescence staining were performed on testicular sections obtained from patients′ biopsies. Intracytoplasmic sperm injection (ICSI) was applied for assisted fertilization. Additionally, small RNA sequencing was performed to identify the abnormalities of piRNA biogenesis. Results: We identified eight variants in PET (PIWI‐EXD1‐TDRD12) complex encoding genes TDRD12 and EXD1 from three NOA patients and one oligoasthenozoospermia patient. These variants, which were rare or absent in public human databases, were predicted to be deleterious. Notably, TDRD12 mRNA was absent in three NOA patients. Testicular histopathological analyses revealed that spermatogenesis was arrested at zygotene stage in patients carrying biallelic TDRD12 variants. Further immunofluorescence staining of L1ORF1p and small RNA sequencing revealed disruptions in piRNA biogenesis and subsequent derepression of retrotransposons. Further assisted reproduction outcomes showed that one of the individuals conceived successfully after ICSI. Conclusion: Overall, this study significantly expands the mutational phenotype of PET complex‐encoding genes and significantly advances our understanding of spermatogenic failure and male infertility. Our findings provide direct clinical and functional evidence that the function of the PET complex and piRNA biogenesis is highly conserved between humans and mice.
- 27 December 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
S-Doped Fe–N–C Single-Atom Nanozyme with Enhanced Oxidase-Like Activity for Colorimetric Detection of Serotonin
Serotonin (5-hydroxytryptamine, 5-HT) is a crucial neurotransmitter, the abnormal levels of which are closely associated with various neuropsychiatric disorders and male reproductive dysfunctions. In this study, a sulfur-doped Fe-N-C single-atom nanozyme (S@Fe-CNx) was successfully synthesized, and its oxidase-like activity and catalytic mechanism were systematically investigated. The experimental results indicate that sulfur doping significantly enhanced Fe-CNx oxygen activation capacity and catalytic kinetics by effectively optimizing the electronic structure of the FeNx active centers. Leveraging its superior oxidase-like activity, we developed a H2O2-free colorimetric sensing method for the highly sensitive and selective detection of 5-HT. The method exhibited a good linear relationship between absorbance and 5-HT concentration in the range of 40 ng/mL to 10 μg/mL, achieving a low limit of detection of 6.0 ng/mL. The successful application of this method for detecting 5-HT in human serum samples demonstrates its great potential for practical use. Furthermore, we established a smartphone-based colorimetric detection platform that quantified 5-HT by correlating its concentration with the grayscale intensity of standard solution images captured by a smartphone. This approach provides a facile strategy for developing point-of-care testing platforms.
- 27 December 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
S-Doped Fe–N–C Single-Atom Nanozyme with Enhanced Oxidase-Like Activity for Colorimetric Detection of Serotonin
Serotonin (5-hydroxytryptamine, 5-HT) is a crucial neurotransmitter, the abnormal levels of which are closely associated with various neuropsychiatric disorders and male reproductive dysfunctions. In this study, a sulfur-doped Fe-N-C single-atom nanozyme (S@Fe-CNx) was successfully synthesized, and its oxidase-like activity and catalytic mechanism were systematically investigated. The experimental results indicate that sulfur doping significantly enhanced Fe-CNx oxygen activation capacity and catalytic kinetics by effectively optimizing the electronic structure of the FeNx active centers. Leveraging its superior oxidase-like activity, we developed a H2O2-free colorimetric sensing method for the highly sensitive and selective detection of 5-HT. The method exhibited a good linear relationship between absorbance and 5-HT concentration in the range of 40 ng/mL to 10 μg/mL, achieving a low limit of detection of 6.0 ng/mL. The successful application of this method for detecting 5-HT in human serum samples demonstrates its great potential for practical use. Furthermore, we established a smartphone-based colorimetric detection platform that quantified 5-HT by correlating its concentration with the grayscale intensity of standard solution images captured by a smartphone. This approach provides a facile strategy for developing point-of-care testing platforms.